Apremilast is effective for the treatment of patients with plaque psoriasis who have limited skin involvement, including in high-impact areas.
Patients with psoriasis with obesity are at an increased risk for primary failure of biologic therapies when compared with those without obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results